Akso Health Group
5 hedge funds and large institutions have $202K invested in Akso Health Group in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.08% less ownership
Funds ownership: 0.48% → 0.4% (-0.08%)
29% less funds holding
Funds holding: 7 → 5 (-2)
41% less capital invested
Capital invested by funds: $343K → $202K (-$141K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$17.7K |
| 2 |
VF
Virtu Financial
New York
|
-$16K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.6K |
| 4 |
Two Sigma Investments
New York
|
-$10.8K |
AHG Hedge Fund Activity: Q4 2023 in Review
5 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q4 2023, worth a combined $202K — down 41% from $343K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AHG and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.69K. The largest seller was Millennium Management, cutting an estimated $17.7K.
- 5 institutional investors held Akso Health Group (AHG) as of Q4 2023, down from 7 in Q3 2023.
- Funds reported $202K of Akso Health Group stock for Q4 2023, down 41% quarter-over-quarter.
- 0 funds opened new Akso Health Group positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest Akso Health Group buyer in Q4 2023 was Renaissance Technologies, an estimated $2.69K added.
- The largest Akso Health Group seller in Q4 2023 was Millennium Management, an estimated $17.7K sold.
Based on aggregated 13F filings for Q4 2023.